Abstract Background Anogenital warts (AGWs) are a common, highly infectious disease
caused by the human papillomavirus (HPV), whose high recurrence rates contribute to direct …

Human papillomavirus (HPV) infection is a central and necessary, although not sufficient,
cause of cervical cancer. Besides HPV, the additional multiple risk factors related with the …

Background Approximately 90% of genital warts (GWs) are caused by human
papillomavirus (HPV) types 6 and 11. Denmark has provided the quadrivalent HPV vaccine …

Background We conducted a large national cohort study to examine the risk of cancer
among men and women with genital warts (GW). Methods By use of the Danish National …

Background Efficacy of the nine-valent human papillomavirus (9vHPV; HPV types
6/11/16/18/31/33/45/52/58) vaccine was demonstrated in a phase 3 study in women 16–26 …

Objective: This study examined the incidence of and healthcare costs attributable to genital
warts within a large US commercially insured, geographically dispersed population …

Asymposium with the primary goal of identifying strategies to increase the adoption of
evidence based consensus guidelines for cervical cancer screening and the management of …

Objectives To estimate the total number of cases of, and cost of care for, genital warts (GWs)
in England, to inform economic evaluations of human papillomavirus vaccination. Methods …

Background Human papilloma virus (HPV) types 6 and 11 account for 90 percent of
anogenital warts (AGW). Assessment of a potential reduction of the incidence of AGW …

Many skin and skin‐related diseases affect the sexes unequally, with attendant implications
for public health and resource allocation. To evaluate better the incidence of skin and skin …